Representatives of the news media will be able to attend CTAD 2014 at no charge and we strongly advise advance registration. Press registration will be issued to credentialed journalists from recognized external print, broadcast, syndicated or online news organizations.
High-speed lines and/or wireless service for access to the Internet will be available to journalists in the Press Office on a first-come, first-served basis. Telephones will be provided in the Press Office on a first-come, first-served basis. A credit card or calling card is required for all non-local calls.
CTAD Embargo Policies
The International Conference on Clinical Trials for Alzheimer’s Disease (CTAD) is an annual conference organized and planned by Alzheimer’s disease clinical researchers to share scientific information with each other. The 7th annual CTAD will be held November 20-22, 2014 in Philadelphia, Pennsylvania. Credentialed members of the media are allowed to receive embargoed content in advance of the conference, including scientific abstracts.
The following embargo policies are strictly enforced:
If you have questions concerning an embargo date and time OR filming and photography, please contact Amy Martin Vogt, Media and Public Relations, at firstname.lastname@example.org or 202-745-5052.
ANT Congrès - 154 avenue de Lodève - 34070 Montpellier - France
E-mail : email@example.com
Tel : + 33 (0) 6 85 54 70 98
Fax : + 33 (0)4 67 10 92 23